home / stock / kmph / kmph quote
Last: | $5.81 |
---|---|
Change Percent: | 0.0% |
Open: | $5.83 |
Close: | $5.81 |
High: | $5.97 |
Low: | $5.78 |
Volume: | 64,126 |
Last Trade Date Time: | 02/28/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.81 | $5.83 | $5.81 | $5.97 | $5.78 | 64,126 | 02-28-2023 |
$5.83 | $5.76 | $5.83 | $5.9235 | $5.63 | 103,647 | 02-27-2023 |
$5.74 | $5.61 | $5.74 | $6.075 | $5.61 | 215,298 | 02-24-2023 |
$5.71 | $5.67 | $5.71 | $5.73 | $5.59 | 121,270 | 02-23-2023 |
$5.63 | $5.3859 | $5.63 | $5.65 | $5.37 | 216,809 | 02-22-2023 |
$5.32 | $5.47 | $5.32 | $5.49 | $5.28 | 175,804 | 02-21-2023 |
$5.5 | $5.35 | $5.5 | $5.61 | $5.35 | 193,177 | 02-20-2023 |
$5.5 | $5.35 | $5.5 | $5.61 | $5.35 | 193,177 | 02-17-2023 |
$5.32 | $5.34 | $5.32 | $5.405 | $5.285 | 72,427 | 02-16-2023 |
$5.39 | $5.42 | $5.39 | $5.52 | $5.3163 | 97,169 | 02-15-2023 |
$5.38 | $5.3 | $5.38 | $5.42 | $5.24 | 135,363 | 02-14-2023 |
$5.34 | $5.5 | $5.34 | $5.5 | $5.28 | 133,200 | 02-13-2023 |
$5.44 | $5.4 | $5.44 | $5.475 | $5.32 | 100,316 | 02-10-2023 |
$5.43 | $5.67 | $5.43 | $5.71 | $5.41 | 134,044 | 02-09-2023 |
$5.6 | $5.61 | $5.6 | $5.71 | $5.5385 | 68,088 | 02-08-2023 |
$5.63 | $5.53 | $5.63 | $5.69 | $5.5199 | 112,054 | 02-07-2023 |
$5.56 | $5.7 | $5.56 | $5.7008 | $5.53 | 96,561 | 02-06-2023 |
$5.59 | $5.58 | $5.59 | $5.81 | $5.58 | 140,752 | 02-03-2023 |
$5.63 | $5.5 | $5.63 | $5.65 | $5.4251 | 146,519 | 02-02-2023 |
$5.47 | $5.44 | $5.47 | $5.49 | $5.31 | 114,519 | 02-01-2023 |
News, Short Squeeze, Breakout and More Instantly...
CELEBRATION, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare disease therapeutics company, today announced that it has become a Corporate Council member of the National Org...
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm, Inc.), today announced it has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission...
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced that the Company will host a conference call and live audio webcast on Tuesday, March 7, 2023, at 8:3...